» Articles » PMID: 1553037

MRI of Pituitary Macroadenomas with Reference to Hormonal Activity

Overview
Journal Neuroradiology
Specialties Neurology
Radiology
Date 1992 Jan 1
PMID 1553037
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

In 115 patients with pituitary macroadenomas, the findings on mid-field MRI were correlated with the hormonal activity of the tumours. Adenomas secreting growth hormone (GH), prolactin (PRL) and clinically nonsecretory adenomas were studied. Tumour size, invasiveness and signal intensity patterns were recorded. Relaxation times and ratios of signal intensity and proton density (relative to the corpus callosum) were analysed in areas of apparently solid tissue in a subgroup of 59 previously untreated patients. Invasiveness was more common in PRL- and GH-secreting adenomas than in the nonsecreting ones. Diffuse invasion of the base of the skull was most common in prolactinomas, and associated with a lower frequency of suprasellar tumour extension. In prolactinomas, a correlation was found between the maximum serum PRL level and tumour size. Haemorrhagic, cystic or necrotic areas were less common in GH-secreting tumours than in the other types. Haemorrhage was more common in prolactinomas than in nonsecreting tumours. MR parameters were similar in prolactinomas and nonsecreting adenomas, but indicated a smaller amount of water in GH-secreting tumours.

Citing Articles

The utility of dynamic MRI in differentiating the hormone-producing ability of pituitary adenomas.

Amano T, Masumoto T, Akutsu H, Sakamoto N, Hoshiai S, Mori K Jpn J Radiol. 2021; 39(8):741-748.

PMID: 33881731 PMC: 8338864. DOI: 10.1007/s11604-021-01121-9.


Associations of Ki-67 Labeling Index with Clinical and Paraclinical Features of Growth Hormone-Secreting Pituitary Adenomas: A Single Center Report from Iran.

Mohseni S, Aboeerad M, Sharifi F, Tavangar S, Mohajeri-Tehrani M Int J Endocrinol Metab. 2019; 17(2):e81983.

PMID: 31372169 PMC: 6628618. DOI: 10.5812/ijem.81983.


Clinicopathological significance of baseline T2-weighted signal intensity in functional pituitary adenomas.

Dogansen S, Yalin G, Tanrikulu S, Tekin S, Nizam N, Bilgic B Pituitary. 2018; 21(4):347-354.

PMID: 29460202 DOI: 10.1007/s11102-018-0877-3.


Evaluation of diffusivity in pituitary adenoma: 3D turbo field echo with diffusion-sensitized driven-equilibrium preparation.

Hiwatashi A, Togao O, Yamashita K, Kikuchi K, Obara M, Yoshiura T Br J Radiol. 2016; 89(1063):20150755.

PMID: 27187598 PMC: 5257300. DOI: 10.1259/bjr.20150755.


Geometric survey on magnetic resonance imaging of growth hormone producing pituitary adenoma.

Bakhtiar Y, Hanaya R, Tokimura H, Hirano H, Oyoshi T, Fujio S Pituitary. 2013; 17(2):142-9.

PMID: 23504370 DOI: 10.1007/s11102-013-0479-z.


References
1.
Wilson C . A decade of pituitary microsurgery. The Herbert Olivecrona lecture. J Neurosurg. 1984; 61(5):814-33. DOI: 10.3171/jns.1984.61.5.0814. View

2.
Karnaze M, Sartor K, Winthrop J, Gado M, HODGES 3rd F . Suprasellar lesions: evaluation with MR imaging. Radiology. 1986; 161(1):77-82. DOI: 10.1148/radiology.161.1.3763887. View

3.
Saeger W, Kant P, Caselitz J, Ludecke D . Electron microscopical morphometry of pituitary adenomas. Comparison of tumours in acromegaly and hyperprolactinemia. Pathol Res Pract. 1988; 183(1):17-24. View

4.
Pusey E, Kortman K, Flannigan B, Tsuruda J, Bradley W . MR of craniopharyngiomas: tumor delineation and characterization. AJR Am J Roentgenol. 1987; 149(2):383-8. DOI: 10.2214/ajr.149.2.383. View

5.
Breger R, Rimm A, Fischer M, Papke R, Haughton V . T1 and T2 measurements on a 1.5-T commercial MR imager. Radiology. 1989; 171(1):273-6. DOI: 10.1148/radiology.171.1.2928538. View